Wealth Advisory Solutions’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.96M | Buy |
42,877
+340
| +0.8% | +$23.5K | 0.75% | 38 |
|
|
2025
Q1 | $2.95M | Buy |
42,537
+3,103
| +8% | +$215K | 0.78% | 40 |
|
|
2024
Q4 | $3.39M | Buy |
39,434
+12,629
| +47% | +$1.09M | 0.95% | 28 |
|
|
2024
Q3 | $3.19M | Sell |
26,805
-3,020
| -10% | -$360K | 0.88% | 32 |
|
|
2024
Q2 | $4.26M | Sell |
29,825
-16,230
| -35% | -$2.32M | 1.15% | 27 |
|
|
2024
Q1 | $5.91M | Buy |
46,055
+489
| +1% | +$62.8K | 1.53% | 17 |
|
|
2023
Q4 | $4.71M | Sell |
45,566
-44,290
| -49% | -$4.58M | 1.65% | 21 |
|
|
2023
Q3 | $8.74M | Buy |
89,856
+45,328
| +102% | +$4.41M | 1.71% | 18 |
|
|
2023
Q2 | $3.6M | Sell |
44,528
-304
| -0.7% | -$24.6K | 0.96% | 29 |
|
|
2023
Q1 | $3.57M | Sell |
44,832
-18,772
| -30% | -$1.49M | 0.95% | 31 |
|
|
2022
Q4 | $4.3M | Sell |
63,604
-68
| -0.1% | -$4.6K | 1.16% | 21 |
|
|
2022
Q3 | $3.17M | Buy |
+63,672
| New | +$3.17M | 0.88% | 38 |
|